Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
about
Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance.Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51.Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.
P2860
Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
@en
type
label
Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
@en
prefLabel
Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
@en
P2093
P2860
P356
P1433
P1476
Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
@en
P2093
Kaitlin N Highsmith
Sandy Horowitz
Sheree E Chen
P2860
P304
P356
10.1002/PHAR.1463
P407
P577
2014-07-19T00:00:00Z